- Home
- Medical news & Guidelines
- Anesthesiology
- Cardiology and CTVS
- Critical Care
- Dentistry
- Dermatology
- Diabetes and Endocrinology
- ENT
- Gastroenterology
- Medicine
- Nephrology
- Neurology
- Obstretics-Gynaecology
- Oncology
- Ophthalmology
- Orthopaedics
- Pediatrics-Neonatology
- Psychiatry
- Pulmonology
- Radiology
- Surgery
- Urology
- Laboratory Medicine
- Diet
- Nursing
- Paramedical
- Physiotherapy
- Health news
- Fact Check
- Bone Health Fact Check
- Brain Health Fact Check
- Cancer Related Fact Check
- Child Care Fact Check
- Dental and oral health fact check
- Diabetes and metabolic health fact check
- Diet and Nutrition Fact Check
- Eye and ENT Care Fact Check
- Fitness fact check
- Gut health fact check
- Heart health fact check
- Kidney health fact check
- Medical education fact check
- Men's health fact check
- Respiratory fact check
- Skin and hair care fact check
- Vaccine and Immunization fact check
- Women's health fact check
- AYUSH
- State News
- Andaman and Nicobar Islands
- Andhra Pradesh
- Arunachal Pradesh
- Assam
- Bihar
- Chandigarh
- Chattisgarh
- Dadra and Nagar Haveli
- Daman and Diu
- Delhi
- Goa
- Gujarat
- Haryana
- Himachal Pradesh
- Jammu & Kashmir
- Jharkhand
- Karnataka
- Kerala
- Ladakh
- Lakshadweep
- Madhya Pradesh
- Maharashtra
- Manipur
- Meghalaya
- Mizoram
- Nagaland
- Odisha
- Puducherry
- Punjab
- Rajasthan
- Sikkim
- Tamil Nadu
- Telangana
- Tripura
- Uttar Pradesh
- Uttrakhand
- West Bengal
- Medical Education
- Industry
Himachal Pradesh gets first installment of Rs 225 crore for Bulk Drug Park
He said that bid process management has also been initiated for selection of consultants for the Environmental Clearance of the Bulk Drug Park.
Himachal Pradesh: The Himachal Pradesh government has received the first installment of grant-in-aid of Rs 225 crore from the Department of Pharmaceuticals, Government of India (GoI) for the development of Common Infrastructure Facilities for the Bulk Drug Park in Una.
Chief Minister, Thakur Sukhvinder Singh Sukhu, while expressing his pleasure on the formation of the State Implementing Agency (SIA) and release of first installment of Rs. 225 crore said that “Bulk Drug Park is a project of national importance and crucial for strengthening the States’ existing pharma ecosystem. This grant-in-aid was given under the scheme guidelines “Promotion of Bulk Drug Park” Scheme notified by the Department of Pharmaceuticals (DoP), Ministry of Chemical and Fertilizer, Government of India (GoI) in 2020.
He further said that keeping in mind the investment potential of around Rs. 8000-10,000 crore and expected employment opportunities for more than 15,000 persons, the State Government would ensure timely execution of this mega Project. He said that the Government has registered the SIA “Himachal Pradesh Bulk Drug Park Infrastructure Limited (HPBDPIL)” with the Ministry of Corporate Affairs on 15th February, 2023.
The Chief Minister said that the department has already completed the planning of external infrastructure for power and road with the respective line departments. As the power demand for this park has been estimated around 120 MW, and continuous Power supply will be required for the operations of API units, adequate planning to draw power, two transmission lines from Una and Tahliwal has been planned. This project will require technical and financial expertise to meet the requirement of capital cost of the project. For that tender has been floated for selection of transaction advisor for providing consultancy services for the selection of “Strategic Investor cum Developer” for Development, Operation, and Maintenance & Management of Bulk Drug Park, said the Chief Minister.
He said that bid process management has also been initiated for selection of consultants for the Environmental Clearance of the Bulk Drug Park.
He said that the government will constitute a Project Coordination Committee for monitoring the progress of timely execution of Bulk Drug Park.
Read also: Himachal Pradesh: PM Modi lays foundation stone of Una Bulk Drug Park
Ruchika Sharma joined Medical Dialogue as an Correspondent for the Business Section in 2019. She covers all the updates in the Pharmaceutical field, Policy, Insurance, Business Healthcare, Medical News, Health News, Pharma News, Healthcare and Investment. She has completed her B.Com from Delhi University and then pursued postgraduation in M.Com. She can be contacted at editorial@medicaldialogues.in Contact no. 011-43720751